Sanitary Act. The European Association for Generic and Biosimilar Medicines has been renamed Medicines for Europe, 'Better Access. Better health', and estimates that "it will grow in volume over the next 5 years, from the current 56 percent to 75 percent," and stating that its industries supply "most of Europe's prescription drugs."